Theranexus Valuation
| ALTHX Stock | EUR 0.66 0.02 2.94% |
Theranexus is undervalued. Theranexus SA has a current Real Value of €0.73 per share. The regular price of the company is €0.66. Our model measures the value of Theranexus SA from inspecting the company fundamentals such as Shares Owned By Insiders of 17.93 %, return on equity of -0.74, and Current Valuation of 3.6 M as well as reviewing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Theranexus' price fluctuation is abnormally volatile at this time. Calculation of the real value of Theranexus SA is based on 3 months time horizon. Increasing Theranexus' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Theranexus' intrinsic value may or may not be the same as its current market price of 0.66, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.66 | Real 0.73 | Hype 0.66 | Naive 0.7 |
The intrinsic value of Theranexus' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Theranexus' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Theranexus SA helps investors to forecast how Theranexus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Theranexus more accurately as focusing exclusively on Theranexus' fundamentals will not take into account other important factors: Theranexus Total Value Analysis
Theranexus SA is presently projected to have takeover price of 3.6 M with market capitalization of 10.3 M, debt of 5.33 M, and cash on hands of 7.01 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Theranexus fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.6 M | 10.3 M | 5.33 M | 7.01 M |
Theranexus Asset Utilization
One of the ways to look at asset utilization of Theranexus is to check how much profit was generated for every dollar of assets it reports. Theranexus SA has a negative utilization of assets of -0.29 %, losing €0.002922 for each euro of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each euro of assets it has. In other words, asset utilization of Theranexus SA shows how discouraging it operates for each euro spent on its assets.Theranexus Ownership Allocation
The market capitalization of Theranexus is €10.3 Million. Theranexus SA has significant amount of outstanding shares owned by insiders and institutional investors .Since such a large part of the company is not owned by regular investors, we recommend to check if there were significant buying or selling the Theranexus SA stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Theranexus Profitability Analysis
Net Loss for the year was (8.15 M) with loss before overhead, payroll, taxes, and interest of (5.47 M).About Theranexus Valuation
The stock valuation mechanism determines Theranexus' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Theranexus SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Theranexus. We calculate exposure to Theranexus's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Theranexus's related companies.Theranexus socit anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company was founded in 2013 and is based in Lyon, France. THERANEXUS is traded on Paris Stock Exchange in France.
8 Steps to conduct Theranexus' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Theranexus' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Theranexus' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Theranexus' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Theranexus' revenue streams: Identify Theranexus' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Theranexus' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Theranexus' growth potential: Evaluate Theranexus' management, business model, and growth potential.
- Determine Theranexus' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Theranexus' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Theranexus Stock Analysis
When running Theranexus' price analysis, check to measure Theranexus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theranexus is operating at the current time. Most of Theranexus' value examination focuses on studying past and present price action to predict the probability of Theranexus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theranexus' price. Additionally, you may evaluate how the addition of Theranexus to your portfolios can decrease your overall portfolio volatility.